Overexpression of yeast hsp104 reduces polyglutamine aggregation and prolongs survival of a transgenic mouse model of Huntington's disease

By Vacher Coralie   Garcia-Oroz Lourdes   Rubinsztein David C.  

Human Molecular Genetics, Vol. 14, Iss. 22, 2005-11 ,pp. : 3425-3433

Oxford University Press

Access to resources Recommend Favorite

Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington’s disease

By Schapira A.  

Human Molecular Genetics, Vol. 10, Iss. 17, 2001-08 ,pp. : 1829-1845

Oxford University Press

Access to resources Recommend Favorite

Suppression of polyglutamine-induced toxicity in cell and animal models of Huntington's disease by ubiquilin

By Wang Hongmin   Lim Precious J.   Vogel Bruce E.   Monteiro Mervyn J.  

Human Molecular Genetics, Vol. 15, Iss. 6, 2006-03 ,pp. : 1025-1041

Oxford University Press

Access to resources Recommend Favorite

Reduction of polyglutamine toxicity by TDP-43, FUS and progranulin in Huntington's disease models

By Tauffenberger Arnaud   Chitramuthu Babykumari P.   Bateman Andrew   Bennett Hugh PJ.   Parker J. Alex  

Human Molecular Genetics, Vol. 22, Iss. 4, 2013-02 ,pp. : 782-794

Oxford University Press

Access to resources Recommend Favorite

α-Synuclein accumulates in huntingtin inclusions but forms independent filaments and its deficiency attenuates early phenotype in a mouse model of Huntington's disease

By Tomás-Zapico Cristina   Díez-Zaera María   Ferrer Isidre   Gómez-Ramos Pilar   Morán María A.   Miras-Portugal M. Teresa   Díaz-Hernández Miguel   Lucas José J.  

Human Molecular Genetics, Vol. 21, Iss. 3, 2012-02 ,pp. : 495-510

Oxford University Press

Access to resources Recommend Favorite